BR112018070429A2 - composições farmacêuticas e alimentícias à base de hafhia alvei para induzir a saciedade e prolongar a saciedade - Google Patents

composições farmacêuticas e alimentícias à base de hafhia alvei para induzir a saciedade e prolongar a saciedade

Info

Publication number
BR112018070429A2
BR112018070429A2 BR112018070429-6A BR112018070429A BR112018070429A2 BR 112018070429 A2 BR112018070429 A2 BR 112018070429A2 BR 112018070429 A BR112018070429 A BR 112018070429A BR 112018070429 A2 BR112018070429 A2 BR 112018070429A2
Authority
BR
Brazil
Prior art keywords
satiety
hafhia
alvei
food compositions
prolong
Prior art date
Application number
BR112018070429-6A
Other languages
English (en)
Inventor
FETISSOV Serguei
Dechelotte Pierre
BRETON Jonathan
Lambert Grégory
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Centre Hospitalier Universitaire De Rouen
Targedys
Université de Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2016/051923 external-priority patent/WO2016193829A1/en
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Centre Hospitalier Universitaire De Rouen, Targedys, Université de Rouen filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Priority claimed from PCT/EP2017/058116 external-priority patent/WO2017174658A1/en
Publication of BR112018070429A2 publication Critical patent/BR112018070429A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a presente invenção refere-se a composições farmacêuticas e alimentícias para induzir a saciedade e prolongar a saciedade em indivíduos em necessidade do mesmo. em particular, a presente invenção refere-se a um método de indução de saciedade em um indivíduo em necessidade do mesmo, compreendendo a administração ao indivíduo de uma quantidade eficaz de hafhia alvei.
BR112018070429-6A 2016-04-05 2017-04-05 composições farmacêuticas e alimentícias à base de hafhia alvei para induzir a saciedade e prolongar a saciedade BR112018070429A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WOPCT/IB2016/051923 2016-04-05
PCT/IB2016/051923 WO2016193829A1 (en) 2015-06-05 2016-04-05 Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
PCT/EP2017/058116 WO2017174658A1 (en) 2014-10-02 2017-04-05 Hafnia alvei based pharmaceutical and food compositions for inducing satiation and prolonging satiety

Publications (1)

Publication Number Publication Date
BR112018070429A2 true BR112018070429A2 (pt) 2019-02-12

Family

ID=58503597

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018070429-6A BR112018070429A2 (pt) 2016-04-05 2017-04-05 composições farmacêuticas e alimentícias à base de hafhia alvei para induzir a saciedade e prolongar a saciedade

Country Status (6)

Country Link
EP (2) EP3721895A1 (pt)
AU (1) AU2017247612B2 (pt)
BR (1) BR112018070429A2 (pt)
DK (1) DK3439684T3 (pt)
IL (1) IL262034A (pt)
PL (1) PL3439684T3 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111248420A (zh) * 2018-11-30 2020-06-09 内蒙古伊利实业集团股份有限公司 一种含有膳食纤维的果酱和发酵乳及其制备方法
CN113265351B (zh) * 2021-05-11 2022-05-06 昆明理工大学 一株乳杆菌w8172及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723358B1 (en) 1998-03-23 2004-04-20 General Mills, Inc. Encapsulation of components into edible products
KR20160101945A (ko) * 2013-12-05 2016-08-26 인스티튜트 내셔널 드 라 싼테 에 드 라 리셰르셰 메디칼르 (인 썸) a-MSH의 ClpB 단백질 모방을 통한 숙주 급식 및 감정의 세균 영향
CA2932488A1 (en) * 2013-12-05 2015-06-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via clpb protein mimicry of alpha-msh
US10682389B2 (en) * 2015-06-05 2020-06-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof

Also Published As

Publication number Publication date
EP3721895A1 (en) 2020-10-14
EP3439684B1 (en) 2020-05-27
EP3439684A1 (en) 2019-02-13
DK3439684T3 (da) 2020-08-03
IL262034A (en) 2018-11-29
AU2017247612B2 (en) 2023-12-07
AU2017247612A1 (en) 2018-11-08
AU2017247612A9 (en) 2018-11-22
PL3439684T3 (pl) 2020-11-02

Similar Documents

Publication Publication Date Title
CL2019000820A1 (es) Compuestos, composiciones y sus usos para inhibir la actividad arginasa. (divisional solicitud 201801134)
CL2021000343A1 (es) Inhibidores peptídicos del receptor de interleucina 23 (divisional de la solicitud n° 201800128)
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
MA49795A (fr) Nouvelle composition de fortification, de nutrition et de protection des cultures
IL262495B (en) History of isoquinolin-3-yl carboxamide and pharmaceutical preparations containing them
MX2018012056A (es) Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad.
BR112017025499A2 (pt) benefícios da suplementação com n-acetil cisteína e glicina para melhorar os níveis de glutationa
CL2020000382A1 (es) Composiciones de aminoácidos para el tratamiento de enfermedad hepática.
ECSP20005593A (es) Composiciones para endulzar y enmascarar sabores, productos y usos de estos
BR112018012304A2 (pt) composições e métodos para diminuir expressão de tau
BR112017012381A2 (pt) imunoterapia para doença angiogênica
MX2017013073A (es) Inhibidores de grelina o-aciltransferasa.
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
CY1122287T1 (el) Ενωσεις χρησιμες για την αναστολη toy ror-γαμμα-τ
MX2017013072A (es) Inhibidores de grelina o-aciltransferasa.
CO2018007621A2 (es) Composiciones y métodos para evaluar el riesgo de ocurrencia de cáncer
DK3275454T3 (da) Farmaceutisk sammensætning med silybin, ve og l-carnitin
BR112017015210A2 (pt) combinação de 25-hidroxi-vitamina d e antioxidantes/anti-inflamatórios para saúde bovina
CO2019002245A2 (es) Combinación de agonistas de fxr
BR112018068027A2 (pt) método para tratar câncer em um paciente e composição farmacêutica
BR112018070429A2 (pt) composições farmacêuticas e alimentícias à base de hafhia alvei para induzir a saciedade e prolongar a saciedade
TR201908639T4 (tr) Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler.
BR112015024703A2 (pt) formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]